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Abstract: Fructose-enriched diets cause salt-sensitive hypertension. Proximal tubules (PTs) reabsorb
70% of the water and salt filtered through the glomerulus. Angiotensin II (Ang II) regulates
this process. Normally, dietary salt reduces Ang II allowing the kidney to excrete more salt,
thereby preventing hypertension. We hypothesized that fructose-enriched diets enhance the ability of
low concentrations of Ang II to stimulate PT transport. We measured the effects of a low concentration
of Ang II (10−12 mol/L) on transport-related oxygen consumption (QO2), and Na/K-ATPase and
Na/H-exchange (NHE) activities and expression in PTs from rats consuming tap water (Control)
or 20% fructose (FRUC). In FRUC-treated PTs, Ang II increased QO2 by 14.9 ± 1.3 nmol/mg/min
(p < 0.01) but had no effect in Controls. FRUC elevated NHE3 expression by 19 ± 3% (p < 0.004) but
not Na/K-ATPase expression. Ang II stimulated NHE activity in FRUC PT (∆ + 0.7 ± 0.1 Arbitrary
Fluorescent units (AFU)/s, p < 0.01) but not in Controls. Na/K-ATPase activity was not affected.
The PKC inhibitor Gö6976 blocked the ability of FRUC to augment the actions of Ang II. FRUC did not
alter the inhibitory effect of dopamine on NHE activity. We conclude that dietary fructose increases
the ability of low concentrations of Ang II to stimulate PT Na reabsorption via effects on NHE.
Keywords: kidney; hypertension; sodium transport; salt sensitivity
1. Introduction
Consumption of fructose has increased dramatically in the past three decades due to addition of
low-cost high-fructose corn syrup to processed foods and sugar-sweetened beverages. In European
countries and the United States, calories ingested from fructose follow a normal distribution with a
mean of approximately 10% of the daily caloric intake coming from this sugar [1–3]. This not only
reduces the quality of the diet [4] but sets the second quartile at risk of ingesting at least 20% of
the calories as fructose [1–3], primarily as sugar-sweetened beverages [3,5]. Dietary fructose causes
hypertension and cardiovascular disease in humans [6–13]. It also causes hypertension in rats fed
comparable amounts of fructose to those consumed by people [14–16]. The increases in blood pressure
occur even when plasma insulin, glucose and/or lipids are within normal ranges [14,17,18].
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Hypertension cannot be sustained without a renal defect or pressure natriuresis would return
blood pressure to normal values. Defects in proximal tubule transport or its regulation result in
changes in blood pressure [19,20]. In this segment, most of the Na enters the cells in exchange for
protons by the apical Na/H exchanger type 3 (NHE3) while the remainder drives sugar, amino acid
and phosphate uptake via other specific transporters. Exit of Na from the cells into the blood is
mediated by Na/K-ATPase.
Ang II is a key regulator of blood pressure primarily via actions on the kidney in general [21],
and the proximal tubule specifically [22]. These effects are mostly mediated via Ang II type 1 receptors
(AT1R) [22] followed by activation of protein kinase C (PKC) [23–26]. AT1R antagonists ameliorate
hypertension in the fructose-fed rat [27–30], indicating that Ang II signaling is involved in the pathology
of this model. We previously reported that acute exposure of proximal tubules to fructose enhances
the ability of a low concentration of Ang II (10−12 mol/L) to elevate NHE activity [16]. Such low
concentrations of Ang II had no effect in the absence of fructose or in the presence of an equimolar
concentration of glucose [16]. However, the effects of dietary fructose on the actions of Ang II in the
proximal tubule remain to be elucidated.
The proximal tubule displays a biphasic response to Ang II. Concentrations ranging from 10−12 to
10−10 mol/L progressively stimulate transport, while concentrations greater than 10−8 mol/L inhibit
it [31,32]. Even though renal cortical Ang II levels are not precisely known, proximal tubule Na
reabsorption is stimulated by normal physiological concentrations of Ang II when animals are on
a normal-salt diet [21,33]. Experiments comparing the effects of Ang II infusion on Na retention in
salt-restricted vs. salt-loaded rats indicate that Ang II levels maximally stimulate Na reabsorption in
rats consuming reduced-salt diets [34,35]. Taken together, these data indicate that, in rats fed normal
salt, renal cortical Ang II likely range from 10−11 mol/L [36,37] to 10−10 mol/L [38–41].
When animals consume excess dietary salt systemic Ang II levels fall by about an order of
magnitude [42]. Thus, plasma Ang II concentrations are around 10−12 mol/L when rats are fed high
salt. Reductions in renal Ang II allow increased urinary Na excretion (UNaV), and thereby elimination
of excess salt. If this process is blocked, salt is retained and an elevation in blood pressure is required
to restore Na balance causing salt-sensitive hypertension [43,44].
Salt sensitivity of blood pressure in rodents eating fructose-enriched diets is well
documented [13,16,45–47]. In a previous study, we have shown that rats consuming 20% fructose
remain normotensive at least two weeks while on normal salt, but addition of 4% salt to the diet
produces an immediate increase in blood pressure [16]. Consistently, salt restriction prevents the
development of hypertension in Sprague Dawley rats given fructose-containing diets ranging from
20% in the drinking water to 66% in the chow [13,16,46]. Such data indicate that fructose interferes
with salt excretion mechanisms. Given that downregulation of the renin/angiotensin system is one of
the primary mechanisms by which excretion of excess salt occurs, we designed this study to evaluate
whether dietary fructose increases the ability of low concentrations of Ang II to stimulate proximal
tubule Na transport.
We hypothesized that 20% fructose in drinking water enhances the ability of 10−12 mol/L Ang
II to stimulate proximal tubule Na reabsorption, and that this is due to activation of PKC and NHE
rather than Na/K-ATPase activity.
2. Materials and Methods
Drugs and Buffers: Unless specified, all drugs and reagents were obtained from Sigma-Aldrich
(St. Louis, MO, USA). The composition of all solutions used in this study is shown in Table 1.
Bicarbonate-Buffered Physiological Saline was continuously bubbled at 37 ◦C with 95% O2/5% CO2.
Osmolality was titrated with mannitol to 300 mOsmol/L. In HEPES-Buffered Physiological Saline,
Acid Pulse Buffer and K-Free HEPES-Buffered Solution, the pH was titrated to 7.5 with NaOH and
osmolality to 300 mOsmol/L with mannitol. The 4X Reaction Media, and the 4X Reaction Media with
Ouabain contained 6 U/mL of Pyruvate Kinase (PK) and 9 U/mL Lactic Dehydrogenase (LDH).
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The PK/LDH enzyme mix (Sigma, St. Louis, MO, USA, P0294) was also source of 1 mmol/L
KCl. Both solutions contained 0.1% of dimethyl sulfoxide (DMSO) used as an ouabain carrier.
The pH-sensitive fluorescent dye 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl
ester (BCECF-AM; Molecular Probes, Eugene, OR, USA) was dissolved daily in anhydrous DMSO and
diluted in HEPES-Buffered Physiological Saline to reach a final concentration of 1 µmol/L.



















NaHCO3 (mmol/L) 25.0 - - - - -
HEPES " - 10.0 10.0 10.0 - -
Imidazole " - - - - 200.0 200.0
NaCl " 114.0 130.0 130.0 120.0 320.0 320.0
KCl " 4.0 4.0 - 4.0 120.0 -
Na2HPO4 " 2.1 2.5 2.5 2.5 - -
NaH2PO4 " 0.4 - - - - -
Mg SO4 " 1.2 1.2 1.2 1.2 20.0 20.0
Ca(Lactate)2 " 2.0 2.0 2.0 2.0 - -
Na3Citrate " 1.0 1.0 1.0 1.0 - -
DL-alanine " 6.0 6.0 6.0 6.0 - -
Glucose " 5.5 5.5 5.5 5.5 - -
NH4Cl " - - - 10.0 - -
EGTA " - - - - 2.0 2.0
Na2ATP " - - - - 20.0 20.0
NADH " - - - - 4.0 4.0
Ascorbic
Acid " - - - - 4.0 4.0
PEP " - - - - 40.0 40.0
Animals: This study was approved by the Case Western Reserve University Institutional Animal
Care and Use Committee. All experiments were conducted in accordance with the National Institutes
of Health Guidelines for the Care and Use of Laboratory Animals. Male Sprague Dawley rats
(Charles River Breeding Laboratories, Wilmington, MA, USA) weighing ~130 g were used in all
protocols. All efforts were made to minimize stress and discomfort.
Protocol 1: To measure blood pressure and run a metabolic panel, 11 animals were randomly
divided into 2 dietary treatments: (1) the Control which drank water purified with a Milli-Q system
(Millipore Sigma, Billerica, MA, USA); and (2) FRUC which drank a 20% fructose solution. Both groups
received an artificial purified diet (TestDiet, St. Louis, MO, USA, #5876) containing ~100 meq/kg
of Na (0.61% if expressed as NaCl). Animals were allowed to acclimate to the facility and the diet
for 4–7 days while drinking tap water. After the acclimation period animals were randomly split
and assigned to either FRUC or Control groups (Day 0). From Day 6 to Day 7, animals were housed
individually, to measure food and water consumption every 24 h. Final weight and blood pressure
were also measured. At Day 8, animals were anesthetized with isoflurane using 100% O2 as a carrier
and underwent terminal surgery. Blood was drawn from the thoracic aorta using a 20 Gauge needle on
a 10 mL heparinized syringe. Immediately after collection pH, Na, K, Cl and Lactate were measured
using a Nova Prime Blood Analyzer (Nova Biomedicals, Walthman, MA, USA). The remainder of
the blood was centrifuged for collection of plasma. Plasma was aliquoted and frozen for insulin
measurements. Insulin was determined using a Rat Insulin ELISA kit (MERCODIA AB, Uppsala,
Sweden) according to manufacturer recommendations.
Protocol 2: For all studies involving tubule dissection or suspensions, animals received regular
rat chow (~100 meq/kg Na), and either: (1) tap water; or (2) 20% fructose in drinking water (FRUC).
After 7–9 days of dietary treatment, the animals were anesthetized with ketamine (100 mg/kg bw IP)
and xylazine (20 mg/kg bw IP), and given 2 IU heparin (IP). Only one sample, either a proximal
tubules suspension or a microdissected proximal tubule was obtained per animal.
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Proximal Tubule Suspensions: Proximal tubule suspensions were generated using methods similar
to those we used before [48]. Briefly, rats were anesthetized and an abdominal u-shaped incision was
made. The kidneys were retro-perfused from the abdominal aorta with 80 mL of Bicarbonate-Buffered
Physiological Saline at 37 ◦C containing 1 mg/mL collagenase and 2 U/mL heparin at 0.7 mL/min.
Immediately after perfusion the kidneys were excised and rapidly cooled by immersion in
Bicarbonate-Buffered Physiological Saline at 4 ◦C. The cortex of each kidney was gently scraped with
a blade, minced and transferred to a 5 mL conical tube. Tissue was disrupted by passing it through
a pipette tip and stirring on ice for 5 min. The resulting suspension was filtered through a 390 µm
mesh, and the tubules recovered by centrifugation at 4 ◦C (100× g for 2 min). The tubules were
rinsed, filtered through a 250 µm mesh, and recovered by centrifugation at 4 ◦C (80× g for 2 min).
The final pellet was resuspended in 5–10 mL of warm, gassed Bicarbonate-Buffered Physiological Saline.
After sitting for 1 min to sediment glomeruli, 3 mL of the upper suspension were taken for experiments.
Oxygen Consumption: QO2 was measured using methods similar to those we reported [49].
Briefly, 2 to 4 mg of protein from proximal tubule suspensions were taken to a final volume of 6 mL in
the chamber of a YSI Model 5301B bath assembly (Yellow Springs Instruments, Yellow Springs, OH,
USA). The chamber was equilibrated at 37 ◦C with a gas mix containing 95% O2/5% CO2 and then
closed. The oxygen tension in the chamber was monitored using a YSI Model 5300 Biological Oxygen
Monitor (Yellow Springs Instruments) attached to a PowerLab (ADInstruments, Colorado Springs,
CO, USA). After stabilization of about 90 s, basal QO2 was recorded for 1 min, and 10−12 mol/L Ang
II was added while QO2 was continuously measured. At the end of the experiment tubules were
recovered by centrifugation to determine protein content. The results were expressed as nmol O2/mg
protein/min.
Western Blotting: Western blotting of fresh samples was conducted using similar techniques as
before [50]. In brief, proximal tubule suspensions were dissolved in lysis buffer (Sigma, CelLyticTM)
containing 1% protease inhibitor cocktail (Sigma, P8340). Lysed samples rested for at least 5 min on ice
and debris was removed by centrifugation (5600× g, 5 min, 4 ◦C). Protein content was determined by
a colorimetric assay. Samples were loaded onto 6% polyacrylamide gels, loading equal amounts of
protein on each lane. Samples from FRUC and Control were processed in pairs and loaded on the same
gel, so each gel had its own control. Electrophoresis was performed at 100 V and proteins transferred
to a 0.45 micron PVDF (polyvinylidene difluoride) membrane (Bio-RAD, Hercules CA, USA) overnight.
After transferring, membranes were cut at about 60 kD. The upper membranes were blotted for
either Na/K-ATPase α1-subunit or NHE3, while the lower parts were blotted for either β-tubulin or
glyceraldehydephosphate dehydrogenase (GAPDH) as loading controls, respectively. Western blots
were conducted as specified in Table 2. All incubations were at room temperature. No membrane
was stripped.
Table 2. Antibodies and Blotting Conditions.
Antibody Provider Catalog Source Blocking Conditions
Number Buffer Dilution Buffer Time
NHE3 Abcam ab95299 Rabbit 5% BSA 1:1000 5% BSA 2 h
α1-Na/K-ATPase Cell Signaling #3010 Rabbit 5% Milk 1:5000 5% Milk 2 h
β-tubulin Abcam ab6046 Rabbit 5% Milk 1:10,000 5% Milk 2 h
GAPDH-HRP Abcam ab9485 - 5% BSA 1:15,000 5% BSA 2 h
2ry anti-Rabbit-HRP GE Healthcare NA9340V Donkey - 1:2500 5% BSA 1 h
* BSA: Bovine Serum Albumin, Milk: non-fat dehydrated bovine milk.
Protein Detection and Densitometry: Membranes were incubated with LumintaTM Classico
Western HRP Substrate (Millipore, Billerica, MA, USA) and the signal detected by exposing a HyBlot
CL (Denver Scientific, Holliston, MA, USA) autoradiography film to the membranes. Films were
scanned in a single session using an EPSON Expression 1680 scanner with EPSON-Scan software
(Settings: positive film, 16-bit greyscale, 600 dpi) and densitometry measured using Image J 1.47p
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software. After densitometry, the average peak-area of all experimental lanes in each membrane
was calculated and the peak-areas of individual lanes were expressed as a fraction of this value.
Results were expressed as Na/K-ATPase/β-tubulin ratio and as NHE3/GAPDH ratio.
Na/K-ATPase activity: The hydrolytic activity of the Na/K-ATPase was measured by coupling
ADP production to 2 enzymatic reactions which produce NAD+, similar to what we have done
before [51]. Briefly, an aliquot of proximal tubule suspension was rinsed with K-Free HEPES-Buffered
Solution and placed on an inverted microscope. Using micro tweezers, 2 tubules totaling not less
than 0.5 mm were transferred to a 0.5 mL “safe-lock”-Eppendorf tube containing 30 µL of 0.7% octyl
glucoside (Sigma—#30887) and either vehicle or Ang II. Tubules were incubated on ice between 10 and
15 min, and then 13 µL of 4X Reaction Media were added to all tubes but the ouabain ones which
received 4X Reaction Media with Ouabain. Samples were incubated at 37 ◦C for 30 min. The reaction
was stopped by adding 53 µL of 0.5 mol/L HCl to each tube and then incubating the mix for 15 min at
37 ◦C. Finally, the whole reaction volume was transferred to a 2 mL Eppendorf tube containing 1 mL of
6 mol/L KOH and incubated at 60 ◦C for 20 min in the dark. All samples were measured on a Hitachi
F2700 spectrofluorometer, exciting at 366 nm and collecting light at 455 nm. A calibration curve was
obtained by adding 0.5 to 3 nmol of ADP to different tubes, which were processed under the same
conditions as the samples. Linear regression of the data provided a slope used to calibrate the assay.
Na/K-ATPase activity was expressed as pmol ATP/mm/min.
Isolation of Proximal Tubules: The abdominal cavity was opened and the left kidney bathed
in ice-cold 150 mmol/L NaCl. The kidney was removed and placed in ice-cold HEPES-Buffered
Physiological Saline at 4 ◦C. Coronal slices were cut and proximal tubules were isolated from the
cortex using microforceps under a stereomicroscope at 4 to 10 ◦C. Tubular segments ranging from
0.7 to 1.0 mm were then transferred to a temperature-regulated chamber and perfused using concentric
glass pipettes at 37 ± 1 ◦C as we have previously described [16,50].
Measurement of NHE Activity Using the NH4Cl Acid Pulse: The intracellular fluorescence
detection system was set up on a Nikon Diaphot inverted microscope (Nikon, Japan). Proximal tubules
were loaded with 1 µM BCECF-AM in the basolateral bath at 37 ± 1 ◦C for 5 min and then washed for
10 min in dye-free HEPES-Buffered Physiological Saline. BCECF was excited alternately at 490 and
450 nm and emitted fluorescence measured using a 510 nm dichroic mirror. Fluorescent images were
taken utilizing a 40X oil immersion objective and a Coolsnap HQ digital camera (Photometrics, Tucson,
AZ, USA), and ratiometric measurements (490/450) were recorded using Metafluor version 7 imaging
software (Universal Imaging, Downington, PA, USA).
After the dye-free washing period measurements were taken once every 2 s for 1 min.
The basolateral bath solution was then switched to the Acid Pulse Buffer. After 20 s, the basolateral
bath was exchanged back to HEPES-Buffered Physiological Saline. This procedure causes an initial
intracellular alkalinization followed by intracellular acidification. The initial rate of intracellular pH
recovery that follows was taken as a measurement of NHE activity and quantified as fluorescent units
per s (AFU/s). Different compounds of interest were then added to the basolateral bath as indicated
in the Results section. After a 10 min re-equilibration period, the NH4Cl acid pulse was repeated.
The recovery rates in both periods were compared.
Systolic Blood Pressure: Blood pressure was measured non-invasively in conscious animals using
the CODA tail-cuff blood pressure system (Kent Scientific, Torrington, CT, USA). Animals were trained
on Days 0, 2 and 4 of the dietary treatment and the final measurement was taken at 9:00 a.m. on Day 7.
Statistics: All data were analyzed using R, version 3.2.3 (R Foundation for Statistical Computing,
Vienna, Austria. URL https://www.R-project.org/). Means were compared using unpaired 2-tailed
Student t-tests. All p values < 0.05 were considered significant. Results are expressed as the arithmetic
mean ± the standard error of the mean of each group, or by the difference between two means ± the
standard error of that difference.
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3. Results
A metabolic panel of this model is presented in Table 3. Animals on both diets gained weight at
the same rate and ingested similar calories. However, the FRUC group ate ~30% less food. There were
no differences in weight or systolic blood pressure after seven days of treatment. Fructose feeding
did not affect the main electrolytes Na, K and Cl, nor the acid–base balance as measured by lactate
and pH. Insulin levels of both groups were within normal range. Together, these data indicate that
consumption of 20% fructose in the drinking water for seven days does not cause metabolic syndrome.
Table 3. Metabolic Panel.
Control (n = 5) Fructose (n = 6) Change Ttest
Mean SEM Mean SEM
Caloric Intake (kcal/24 h) 69.9 6.0 65.5 3.2 = p < 0.51
Weight Gain (g/24 h) 9.4 1.3 9.2 2.4 = p < 0.94
Fluid Intake (mL/24 h) 29.2 4.6 25.8 3.1 = p < 0.55
Food Intake (g/24 h) 17.4 1.5 12.0 0.5 ↓ p < 0.01
Final Weight (g) 236 7 232 10 = p < 0.72
Systolic BP (mmHg) 130 11 147 6 = p < 0.18
Control Fructose Change Ttest
Mean SEM Mean SEM
pH 7.42 0.01 7.38 0.03 = p < 0.18
Na (mmol/L) 136.6 0.6 137.5 0.5 = p < 0.31
K (mmol/L) 3.8 0.2 3.7 0.1 = p < 0.73
Cl (mmol/L) 106.4 0.5 106.0 0.3 = p < 0.55
Lactate (mmol/L) 1.02 0.14 1.03 0.07 = p < 0.98
Insulin (µg/mL) 0.38 0.14 0.36 0.15 = p < 0.93
We started testing our hypothesis by studying whether a low concentration of Ang II affects
transport in proximal tubules suspensions. We found that Ang II (10−12 mol/L) stimulated QO2
by 14.9 ± 3 nmol/mg/min (p < 0.01, n = 12) in suspensions from FRUC. In contrast, QO2 was
96 ± 4 nmol/mg/min before Ang II and 99 ± 6 nmol/mg/min afterwards in Control suspensions
(Figure 1). Thus, although basal transport rates were similar in both groups, Ang II (10−12 mol/L) only
enhanced QO2 in suspensions from the rats on the fructose diet. To show that the lack of an effect of
10−12 Ang II in control suspensions was not due to a complete inability to respond to Ang II, we tested
10−9 Ang II and found no difference between groups in total QO2 (FRUC 116 ± 5 nmol/mg/min
vs. 115 ± 7 nmol/mg/min in Control; n = 12).
Nutrients 2017, 9, 885 6 of 15 
 
and pH. Insulin levels of both groups were within normal range. Together, these data indicate that 
consumption of 20% fructose in the drinking water for seven days does not cause metabolic 
syndrome. 
Table 3. Metabolic Panel. 
  Control (n = 5) Fructose (n = 6) Ch nge Ttest 
  Mean SEM Mean SEM   
Caloric Intake (kcal/24 h) 69.9 6.0 65.5 3.2 = p < 0.51 
Weight Gain (g/24 h) 9.4 1.3 9.2 2.4 = p < 0.94 
Fluid Intake (mL/24 h) 29.2 4.6 25.8 3.1 = p < 0.55 
Food Intake (g/24 h) 17.4 1.5 12.0 0.5 ↓ p < 0.01 
Fin  Weight (g) 236 7 232 10 = p < 0.72 
Systolic BP (mmHg) 130 11 147 6 = p < 0.18 
  Control Fructose Change Ttest 
  Mean SEM Mean SEM   
pH  7.42 0.01 7.38 0.03 = p < 0.18 
Na (mmol/L) 136.6 0.6 137.5 0.5 = p < 0.31 
K (mmol/L) 3.8 0.2 3.7 0.1 = p < 0.73 
Cl ( ol/L) 106.4 0.5 106.0  0.3 = p < 0.55 
Lactate (mmol/L) 1.02 0.14 1.03 0.07 = p < 0.98 
Insulin ( / L) 0.38 0.14 0.36 0.15 = p < 0.93 
e started testing our hypothesis by studying hether a lo  concentration of ng II affects 
trans ort in roxi al tubules suspensions. We found that Ang II (10−12 mol/L) stimulated QO2 by 14.9 
± 3 nmol/mg/ in (p < 0.01, n = 12) in suspensions from FRUC. In contrast, QO2 was 96 ± 4 
nmol/mg/min before Ang II and 99 ± 6 nmol/mg/ in afterwards in Control suspensions (Figure 1). 
Thus, although basal transport rates were similar in both groups, Ang II (10−12 mol/L) only enhanced 
QO2 in suspensions from the rats on the fructose diet. To show that the lack of an effect of 10−12 Ang 
II in control suspensions was not due to a complete inability to respond to Ang II, we tested 10−9 Ang 
II and found no difference between groups in total QO2 (FRUC 116 ± 5 nmol/mg/min vs. 115 ± 7 
nmol/mg/min in Control; n = 12). 
 
Figure 1. Effect of 10−12 mol/L Ang II on QO2 in proximal tubule suspensions from rats consuming 
either 20% fructose (FRUC) or tap water (Control). Ang II stimulated QO2 in FRUC (n = 12) but not in 
Controls (n = 12). In FRUC, * indicates p < 0.01 for 10−12 mol/L Ang II vs. basal. 
Transport rates are determined in part by transporters’ abundance. Thus, we assessed protein 
levels of the two main Na transporters in proximal tubules, the α1 subunit of Na/K-ATPase and 
Figure 1. Effect of 10−12 mol/L Ang II on QO2 in proximal tubule suspensions from rats consuming
either 20% fructose (FRUC) or tap water (Control). Ang II stimulated QO2 in FRUC (n = 12) but not in
Controls (n = 12). In FRUC, * indicates p < 0.01 for 10−12 mol/L Ang II vs. basal.
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Transport rates are determined in part by transporters’ abundance. Thus, we assessed protein
levels of the two main Na transporters in proximal tubules, the α1 subunit of Na/K-ATPase and NHE3
by Western blots. We found no difference in the α1-subunit/β-tubulin ratio of tubules from the two
dietary groups (1.06 ± 0.1 vs. 0.97 ± 0.10; Figure 2A). In contrast, we found that the NHE3/GAPDH
optical density ratio was 1.10 ± 0.03 in tubules from FRUC and 0.90 ± 0.03 in controls (∆ + 19 ± 3%;
p < 0.004; Figure 2B).
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(10−9 mol/L) used as a positive control stimul ted Na/K-ATPase activity to the same extent in tubules
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Figure 3. Effect of 10−12 mol/L Ang II on Na/K-ATPase hydrolytic activity, in permeabilized proximal
tubule from rats consuming either 20% fructose (FRUC) or tap water (Control).
NHE3 activity was assessed by pH recovery in isolated perfused proximal tubules. Addition of
10−12 mol/L Ang II had no significant effect on pH recovery in Control tubules which recovered at a
rate of 2.0 ± 0.2 arbitrary fluorescent units (AFU)/s without and at 1.8 ± 0.1 with 10−12 mol/L Ang II
(∆ − 0.2 ± 0.2 AFU/s). In the FRUC tubules, Ang II increased recovery by 0.7 ± 0.1 AFU/s (p < 0.01;
n = 5; Figure 4). These results show that a low concentration of Ang II only stimulated NHE in tubules
from rats receiving fructose in the drinking water.
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Figure 4. Effect of 10−12 mol/L Ang II on pH recovery after an NH4 pulse in proximal tubules isolated
from rats consuming either 20% fructose (FRUC) or tap water (Control).
We next studied whether changes in Ang II signaling could be affecting NHE3 activity.
When PKCα/β1 were inhibited, the pH recovery rate in the presence of Ang II (10−12 mol/L) in tubules
from animals on fructose was 1.2 ± 0.2 AFU/s, not different from the 1.9 ± 0.6 AFU/s in its absence
(n = 5; Figure 5). These data indicate that, upon PKCα/β1 inhibition, FRUC tubules lack the ability to
increase pH recovery in response to 10−12 mol/L Ang II. This concentration of Ang II has no effect on
pH recovery in controls (Figure 4).
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Impairment of inhibitory signals could be augmenting a positive response to Ang II. Thus, we
explored whether the response to natriuretic factors was altered by fructose by measuring the effect of
the dopamine receptor 1 (D1) agonist fenoldopam on NHE3 activity. We found that, in tubules from
FRUC rats, fenoldopam (10−6 mol/L) reduced the rate of pH recovery by 1.1 ± 0.6 AFU/s (n = 7).
This value was not significantly different from the recovery rate in controls after the D1 agonist of
0.6 ± 0.4 AFU/s (n = 5; Figure 6). This indicates that the enhanced sensitivity to Ang II is not mediated
by an altered response to a natriuretic factor.
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4. Discussion
We previously reported that 20% fructose in the drinking water predisposes animals to
salt-sensitive hypertension, and that acute exposure to fructose increases the sensitivity of control
proximal tubules to Ang II [16]. In the present study, we explored whether dietary fructose enhances
the ability of low concentrations of Ang II (10−12 mol/L) to augment proximal tubule Na reabsorption
and the transporters involved. We also characterized the model showing that a moderately enriched
fructose diet does not cause overt metabolic syndrome within seven days. Thus, it is important to
distinguish the model presented here from models with longer-term treatments (≥2 weeks) used to
in uce metabolic syn rome [52].
To test our hypothesis, we first measured whether a low concentration of Ang II (10−12 mol/L)
stimulated QO2 by pr ximal tubule suspensions from rats given either 20% fructose or tap water.
We found that a low Ang II (10−12 mol/L) i creased QO2 by proximal tubules from rats given 20%
fructose in their drinking water for a week but not in control suspensions.
QO2 can be used as a r pid screening tool for chang s in transcellular Na transport because
proximal tubules produce ATP via aerobic metabolism, and Na/K-ATPase uses 60–70% of the ATP
su ply to drive Na acr ss the basolateral membrane. Thus, our data indicate that a 2 % fructose diet
causes low concentr tions of Ang II to stimulate Na reabsorption.
One mecha ism by which the response of Na reabsorpti n to a low concentration of Ang II could
be enhanc d is by i creased expression of Na transporters. Consequently, we m asured the expressi n
of Na/K-ATPase and NHE3, which m diate Na exit from the cell acr s the basolateral membrane
and mo t Na entry across the apical membrane, respectively. Our data indicate that a 20% fructose
diet alters NHE3 but not Na/K-ATPa e expression after one week. However, it is important to note
that total transporter expressio does not nece sarily correlate with activity. Ev n more accurate
measurements of transporter expr ssion, such as the number of units in the plasma membrane, should
be taken with c ution when estimating transport rates. Thus, the modest inc ease i NHE3 reported
here ay or may not alter actual Na reabsorptio in vivo.
To circumvent t es problems nd directly address t ansp t, we measured Na/K-ATPase and
NHE activities. We found that dietary fructos did not alter basal uabain-s nsitive ATP hydrolysis,
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a measure of Na/K-ATPase activity. Furthermore, a low concentration of Ang II did not affect
Na/K-ATPase activity in either FRUC or control suspensions. These data indicate that dietary fructose
does not directly alter Na/K-ATPase activity or the ability of Ang II to regulate it. These experiments
also show a trend of lower Na/K-ATPase activities in the FRUC group. Even though this difference was
not significant, a shift in Na/K-ATPase activity may represent the initiation of a pressure natriuretic
response [53]. This counter regulatory mechanism could be buffering the enhanced sensitivity to
Ang II to prevent elevations in blood pressure. Finally, a limitation of our results is that we did
not study whether dietary fructose alters the K1/2 for either Na or K. Given that intracellular Na is
near the K1/2 of the Na/K-ATPase for Na, a change in this parameter could alter activity. However,
while Ang II has been reported to increase maximum Na/K-ATPase activity [54], there are no reports
to our knowledge that it alters the K1/2 for Na. It is unlikely that an increase in the affinity for K
could affect Na/K-ATPase activity under normal physiological circumstances because K is nearly
always saturating.
While assessing NHE3 activity, we found that a low concentration of Ang II increased pH recovery
in proximal tubules from FRUC rats but not in controls. These results are the first to show such an
effect, and likely explain the QO2 data. Examining these data, one might well ask how tubules
from FRUC increase QO2 and NHE3 activity in response to Ang II (10−12 mol/L) without elevating
Na/K-ATPase activity. The answer to this apparent discrepancy is rather simple. The Na/K-ATPase
experiments were designed to test direct actions of Ang II on this transporter. Thus, ATP hydrolytic
activity was measured in permeabilized tubules in which intracellular Na (Nai) was equilibrated
with the extracellular media. The corollary of the data is that the increase in Na/K-ATPase activity
necessary to support higher transport rates in FRUC is not achieved by a direct effect of Ang II on
this transporter; instead, an elevated intracellular Na secondary to an increase in NHE activity drives
the Na/K-ATPase. This explanation is supported by the literature in which stimulation of proximal
tubules with Ang II triggers transient increases in Nai of up to 8 mmol/L [32,55]. Such an increase in
Nai would be expected to double the resting levels of about 10 mmol/L [32], and elevate Na/K-ATPase
activity near to its maximum velocity [49].
Our data showing that dietary fructose enhances the sensitivity of proximal tubules to Ang II
is novel, and the present study is the first addressing the chronic effect of fructose consumption on
proximal tubule transport. However, the acute effects of fructose on tubular transport have been
measured previously. We reported that short-term incubation with millimolar concentrations of
fructose increase NHE activity in response to 10−12 mol/L Ang II in isolated perfused proximal
tubules [16]. Another group reported that millimolar concentrations of fructose increased bicarbonate
transport in proximal tubules using micropuncture [56]. In both reports, the effects of fructose were
unique and not shared by other hexoses [16,56].
Urinary and plasma fructose concentrations correlate with fructose intake [57–59] leading to
elevated concentrations in the environment surrounding proximal tubules. The proximal tubule
reabsorbs ~70% of filtered water which would be expected to increase the intraluminal concentration
of fructose by a factor of 3–4 compared to plasma. After ingesting a 20% fructose solution,
the urinary concentration of fructose can reach up to 40 mmol/L in humans [60]. Based on this,
the fructose concentration in the proximal tubule can be back calculated to 3–4 mmol/L, comparable to
concentrations that increase transport in vitro [16,56]. This suggests that the effects of a 20% fructose
diet are likely due to fructose per se in the proximal tubule.
In our current work, we observed differences in transport rates in tubular suspensions and isolated
perfused tubules, preparations in which variables such as arterial pressure, renal hemodynamics,
plasma signaling molecules and even fructose itself have been eliminated. This necessarily means that
the effects of fructose are not limited to short postprandial periods when fructose concentrations in
plasma and urine are elevated. Thus, the effects of fructose are long-lasting and do not depend on
acute changes in circulating factors or intact renal nerves and architecture.
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The mechanisms by which dietary fructose enables low concentrations of Ang II to stimulate
proximal tubule Na reabsorption are not completely understood. We found that the PKC α/β1 inhibitor
Gö6976 blunted the ability of a low concentration of Ang II to stimulate NHE activity in proximal
tubules from rats fed 20% fructose. Thus, PKC α or β1 likely are crucial to the actions of dietary fructose.
Classical PKC isoforms (α, β, γ), which are diacylglycerol- and Ca-dependent, have been shown to
mediate the stimulation of fluid and bicarbonate reabsorption caused by Ang II [23–26]. Activation
of this family of kinases has been reported to increase in several tissues from fructose-fed rats [61,62].
Proximal tubules generate diacylglycerols from fructose via dihydroacetone-phosphate [63–66].
Thus, dietary fructose may be increasing diacylglycerol formation, which in turn primes PKC such
that lower concentrations of Ang II can activate it and stimulate transport.
In contrast to the effect on NHE activity, dietary fructose does not allow a low concentration of Ang
II to stimulate Na/K-ATPase activity. These results appear to be consistent with the literature, as PKC
has been reported to have disparate effects on this transporter [67]. Early metabolic studies in proximal
tubule suspensions showed that phorbol esters first stimulate and then inhibit ouabain-sensitive QO2.
The stimulatory phase was inhibited by amiloride, and when Nai was equalized with amphotericin
B the inhibition phase was still observed. The authors concluded that the initial stimulation of
Na/K-ATPase was secondary to an increase in Nai and the inhibitory effect was dependent on
PKC [68]. Other studies demonstrated that the regulation of Na/K-ATPase by PKC is also modulated
by PKA and Nai [67,69,70]; and phorbol esters, which stimulate classical PKCs, inhibit Na/K-ATPase
activity [70].
Finally, we tested whether alterations in natriuretic signaling contribute to the enhanced sensitivity
to Ang II. We measured whether a 20% fructose diet affects dopamine signaling mediated by D1s
because dopamine is a major regulator of proximal tubule transport [71,72] and D1s directly interact
with the AT1R counteracting their actions [73,74]. Thus, a reduction in D1 signaling would result in
less inhibition of the stimulatory effect of Ang II. Our results indicate D1 signaling is not impaired
in this model; this is of particular importance since the interaction between D1 and AT1R occurs at
the receptor level [75], which reinforces the idea that the changes in sensitivity to Ang II are due to
downstream signaling.
In summary, consumption of 20% fructose in drinking water for one week causes an increase in
transport rates by the proximal tubule in response to low concentrations of Ang II that is associated
with intracellular pathways involving lipid-dependent PKC isoforms.
5. Conclusions
In industrialized countries, the average fructose consumption represents nearly 10% of the total
caloric intake [1–3]. This sets the second quartile at risk of ingesting 20% or more of total calories as
fructose [1–3]. The increase in the incidence of hypertension over the last 40 years mirrors the increase
in dietary fructose and salt. Our present study suggests that part of the increase in blood pressure
associated with fructose consumption is due to an enhanced Ang II sensitivity in proximal tubules.
This may provide an explanation for why Ang II receptor blockers frequently reduce blood pressure
to a greater extent than Ang II converting enzyme inhibitors. It also suggests that reducing dietary
fructose in hypertensive patients may be comparable to reducing salt intake, with the added benefits of
being easier for patients to reduce fructose intake over salt, given that better substitutes are available.
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